These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 36732709)
1. Alcohol treatment discussions and clinical outcomes among patients with alcohol-related cirrhosis. Alexandre W; Muhammad H; Agbalajobi O; Zhang G; Gmelin T; Adejumo A; Noll A; Jonassaint NL; DiMartini A; Bataller R; Rogal SS BMC Gastroenterol; 2023 Feb; 23(1):29. PubMed ID: 36732709 [TBL] [Abstract][Full Text] [Related]
2. Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis. Rogal S; Youk A; Zhang H; Gellad WF; Fine MJ; Good CB; Chartier M; DiMartini A; Morgan T; Bataller R; Kraemer KL Hepatology; 2020 Jun; 71(6):2080-2092. PubMed ID: 31758811 [TBL] [Abstract][Full Text] [Related]
3. Incidence and Progression of Alcohol-Associated Liver Disease After Medical Therapy for Alcohol Use Disorder. Vannier AGL; Shay JES; Fomin V; Patel SJ; Schaefer E; Goodman RP; Luther J JAMA Netw Open; 2022 May; 5(5):e2213014. PubMed ID: 35594048 [TBL] [Abstract][Full Text] [Related]
4. Patient- and provider-level factors that underlie alcohol use disorder treatment offer and acceptance in veterans with cirrhosis. Chaudhari RB; Duong N; Shrestha S; Badal B; Dharia N; Robalino Gonzaga E; Spoutz P; Chia L; Wade JB; Rogal S; Bajaj JS Alcohol Clin Exp Res; 2022 May; 46(5):809-814. PubMed ID: 35312086 [TBL] [Abstract][Full Text] [Related]
5. Gender Disparities in Alcohol Use Disorder Treatment Among Privately Insured Patients with Alcohol-Associated Cirrhosis. Mellinger JL; Fernandez A; Shedden K; Winder GS; Fontana RJ; Volk ML; Blow FC; Lok ASF Alcohol Clin Exp Res; 2019 Feb; 43(2):334-341. PubMed ID: 30667521 [TBL] [Abstract][Full Text] [Related]
6. Characterizing the Variation of Alcohol Cessation Pharmacotherapy in Primary Care. Bernstein E; Guo N; Goto T; Rothberg MB J Gen Intern Med; 2021 Jul; 36(7):1989-1996. PubMed ID: 33515195 [TBL] [Abstract][Full Text] [Related]
7. Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate. Singal AK; DiMartini A; Leggio L; Arab JP; Kuo YF; Shah VH Alcohol Alcohol; 2022 Sep; 57(5):576-580. PubMed ID: 35544033 [TBL] [Abstract][Full Text] [Related]
8. A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease. Twohig PA; Balasanova A; Cooper L; Le M; Khoury N; Manatsathit W; Olivera M; Peeraphatdit TB J Addict Med; 2024 Aug; ():. PubMed ID: 39150074 [TBL] [Abstract][Full Text] [Related]
9. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV. Frost MC; Matson TE; Tsui JI; Williams EC Drug Alcohol Depend; 2019 Jan; 194():288-295. PubMed ID: 30469100 [TBL] [Abstract][Full Text] [Related]
10. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis. Rabiee A; Mahmud N; Falker C; Garcia-Tsao G; Taddei T; Kaplan DE Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972386 [TBL] [Abstract][Full Text] [Related]
11. Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis. Pearson MM; Kim NJ; Berry K; Moon AM; Su F; Vutien P; Green PK; Williams EC; Ioannou GN Hepatol Commun; 2021 Dec; 5(12):2080-2095. PubMed ID: 34601829 [TBL] [Abstract][Full Text] [Related]
12. Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease. Vannier AGL; Przybyszewski EM; Shay J; Patel SJ; Schaefer E; Goodman RP; Luther J Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1571-1580.e7. PubMed ID: 35964893 [TBL] [Abstract][Full Text] [Related]
13. Geographic differences in receipt of addictions treatment in a national sample of patients with alcohol use disorders from the U.S. Veterans Health Administration. Edmonds AT; Bensley KM; Hawkins EJ; Williams EC Subst Abus; 2021; 42(4):559-568. PubMed ID: 32821028 [No Abstract] [Full Text] [Related]
14. Simultaneous Management of Alcohol Use Disorder and Liver Disease: A Systematic Review and Meta-analysis. Elfeki MA; Abdallah MA; Leggio L; Singal AK J Addict Med; 2023 Mar-Apr 01; 17(2):e119-e128. PubMed ID: 36259647 [TBL] [Abstract][Full Text] [Related]
15. Alcohol use disorder and the liver. Buchanan R; Sinclair JMA Addiction; 2021 May; 116(5):1270-1278. PubMed ID: 32710592 [TBL] [Abstract][Full Text] [Related]
16. Alcohol use disorder treatment and outcomes among hospitalized adults with alcoholic hepatitis. Winters AC; May FP; Wang Y; Shao P; Yang L; Patel AA Drug Alcohol Depend Rep; 2021 Dec; 1():100004. PubMed ID: 36843910 [No Abstract] [Full Text] [Related]
17. Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia. Gupta NM; Lindenauer PK; Yu PC; Imrey PB; Haessler S; Deshpande A; Higgins TL; Rothberg MB JAMA Netw Open; 2019 Jun; 2(6):e195172. PubMed ID: 31173120 [TBL] [Abstract][Full Text] [Related]
18. Closing the Care Gap: Management of Alcohol Use Disorder in Patients with Alcohol-associated Liver Disease. Green EW; Byers IS; Deutsch-Link S Clin Ther; 2023 Dec; 45(12):1189-1200. PubMed ID: 38052695 [TBL] [Abstract][Full Text] [Related]
19. Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease. Lékó AH; Leggio L Clin Liver Dis; 2024 Nov; 28(4):779-791. PubMed ID: 39362721 [TBL] [Abstract][Full Text] [Related]
20. The association between mental illness and all-cause mortality in patients with cirrhosis: a Veterans Affairs retrospective cohort study. Shaffer LR; Kaplan DE; Taddei TH; Mahmud N Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36996031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]